Soo-Il Jung

Title: Innovations of Soo-Il Jung in Angiogenesis Inhibition

Introduction

Soo-Il Jung is a notable inventor based in Kyonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of processes for purifying angiogenesis inhibitors. His work is crucial for advancing treatments for various cancers and other medical conditions.

Latest Patents

Soo-Il Jung holds a patent for the "Process of purifying angiogenesis inhibitors." This invention relates to the purification of angiogenesis inhibitor proteins expressed in recombinant kringle 1-3, also known as greenstatin. The process involves solubilizing, refolding, and purifying the proteins to obtain a pure and active form. The purified greenstatin specifically suppresses endothelial cell proliferation, angiogenesis, and the growth of lung cancer, skin cancer, and brain tumors. This innovative process is applicable for the mass production of angiogenesis inhibitor proteins, which are beneficial for treating glaucoma, retinopathy, and various cancers.

Career Highlights

Soo-Il Jung is associated with Korea Greencross Corporation, where he continues to work on innovative solutions in the field of biotechnology. His expertise in protein purification and cancer treatment has positioned him as a valuable asset in his organization.

Collaborations

Soo-Il Jung has collaborated with notable colleagues, including Weon Kyoo You and Seung Ho So. Their combined efforts contribute to the advancement of research and development in the field of angiogenesis inhibitors.

Conclusion

Soo-Il Jung's innovative work in the purification of angiogenesis inhibitors represents a significant advancement in cancer treatment. His contributions are vital for the development of effective therapies that can improve patient outcomes.